Atherogenics Inc

CIK 1107601 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Atherogenics Inc.

Recent SEC filings

FiledFormAccession number
Feb 16, 2010SC 13G/A0001080171-10-000008
Feb 12, 2010SC 13G/A0001193125-10-030588
Jun 22, 200915-12G0000950123-09-015872
Jun 22, 20098-K0000950123-09-015789
Jun 16, 20098-K0000950123-09-014351
Jun 12, 200910-Q0000950123-09-013797
Jun 2, 200910-K0000950123-09-010453
May 20, 20098-K0001107601-09-000031
May 19, 2009S-8 POS0001107601-09-000028
May 19, 2009S-8 POS0001107601-09-000029
May 19, 2009S-8 POS0001107601-09-000026
May 19, 2009S-8 POS0001107601-09-000027
May 18, 2009NT 10-Q0001107601-09-000022
Apr 20, 20098-K0001107601-09-000020
Apr 1, 20098-K0001107601-09-000017
Apr 1, 2009NT 10-K0001107601-09-000018
Mar 27, 20098-K0001107601-09-000014
Mar 26, 200925-NSE0001354457-09-000072
Mar 23, 20098-K0001107601-09-000012
Mar 18, 20098-K0001107601-09-000010
Feb 20, 20098-K0001107601-09-000008
Feb 13, 2009SC 13G/A0001193125-09-028839
Feb 13, 2009SC 13G0001080171-09-000010
Feb 12, 2009SC 13G/A0001193125-09-026767
Feb 5, 200950001107601-09-000005